VOR: Vor Biopharma Inc.
Performance
VOR +6.84%
Watchlist
Select an item
Summary
VOR at a glance
VOR returned +6.84% over the past year and -43.79% a year over five years. Its worst drop in that year was -63.51%, smaller than 10% of stocks on Redstone, and its Sharpe ratio of 0.59 beats 55% of stocks on Redstone. It pays no dividends.
Current Drawdown
-20.40%
Rolling Volatility
63.88%
Actions
Metrics
Risk Indicators
Alpha46.43%
Beta1.60x
Sharpe0.59
Sortino0.86
Omega1.12
Calmar0.11
Martin2.44
Profile
About VOR
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $1.2B
- Listed
- Feb 2021
- Employees
- 76
- Headquarters
- Boston, MA
- Website
- vorbio.com
Comparisons